Analysts Viewpoint Investing in Immunome Inc (IMNM): What You Must Know Immunome Inc’s recent filing unveils that its Director BIENAIME JEAN JACQUES acquired Company’s shares for reported $46900.0 on Jun 03
Insiders Updates IMNM price target predicted to rise nearly 33 in 12 months The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or